THE CONAFAY GROUP, LLC

Lobbying for REVAGENIX, INC. · Biopharmaceutical company creating anti-infective medicines.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Opportunities to promote antimicrobial drug development.

Health Issues

Opportunities to promote antimicrobial drug development.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.